Biomimetic proteoglycans as a tool to engineer the structure and mechanics of porcine bioprosthetic heart valves
Journal of Biomedical Materials Research Part B: Applied Biomaterials · 2024
DOI: 10.1002/jbm.b.35336 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biomedical Materials Research Part B: Applied Biomaterials, 2024. Verfasst von Mark Petrovic und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Materials Science and Engineering, Drexel University, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Heart Valve Prosthesis, Bioprosthesis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS, NIH HHS, National Science Foundation.
Abstract (Originalsprache)
The utility of bioprosthetic heart valves (BHVs) is limited to certain patient populations because of their poor durability compared to mechanical prosthetic valves. Histological analysis of failed porcine BHVs suggests that degeneration of the tissue extracellular matrix (ECM), specifically the loss of proteoglycans and their glycosaminoglycans (GAGs), may lead to impaired mechanical performance, resulting in nucleation and propagation of tears and ultimately failure of the prosthetic. Several strategies have been proposed to address this deterioration, including novel chemical fixatives to stabilize ECM constituents and incorporation of small molecule inhibitors of catabolic enzymes implicated in the degeneration of the BHV ECM. Here, biomimetic proteoglycans (BPGs) were introduced into porcine aortic valves ex vivo and were shown to distribute throughout the valve leaflets. Incorporation of BPGs into the heart valve leaflet increased tissue overall GAG content. The presence of BPGs also significantly increased the micromodulus of the spongiosa layer within the BHV without compromising the chemical fixation process used to sterilize and strengthen the tissue prior to implantation. These findings suggest that a targeted approach for molecularly engineering valve leaflet ECM through the use of BPGs may be a viable way to improve the mechanical behavior and potential durability of BHVs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Materials Science and Engineering, Drexel University, Philadelphia, Pennsylvania, USA.
- Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
- School of Biomedical Engineering, Science and Health Systems, Drexel University, Philadelphia, Pennsylvania, USA.
- Department of Mechanical Engineering, Villanova University, Villanova, Pennsylvania, USA.
ORCID-Profile: Mark Petrovic
Förderung
- NIAMS NIH HHS
- NIH HHS
- National Science Foundation
- National Institutes of Health
Zitieren
APA
Petrovic, M., Kahle, E. R., Han, L., & Marcolongo, M. S. (2024). Biomimetic proteoglycans as a tool to engineer the structure and mechanics of porcine bioprosthetic heart valves. Journal of Biomedical Materials Research Part B: Applied Biomaterials. https://doi.org/10.1002/jbm.b.35336
Vancouver
Petrovic M, Kahle ER, Han L, Marcolongo MS. Biomimetic proteoglycans as a tool to engineer the structure and mechanics of porcine bioprosthetic heart valves. Journal of Biomedical Materials Research Part B: Applied Biomaterials. 2024. doi:10.1002/jbm.b.35336
BibTeX
@article{Petrovic2024,
author = {Petrovic, Mark and Kahle, Elizabeth R and Han, Lin and Marcolongo, Michele S},
title = {Biomimetic proteoglycans as a tool to engineer the structure and mechanics of porcine bioprosthetic heart valves},
journal = {Journal of Biomedical Materials Research Part B: Applied Biomaterials},
year = {2024},
doi = {10.1002/jbm.b.35336}
}
EUVIMED